Evidence map›Paper›PMID 32147864›Full record

ArticleLasers in surgery and medicine2020

High Interobserver Agreement in the Subjective Classification of 5-Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas.

Mario Mischkulnig, Barbara Kiesel, Martin Borkovec, Lisa I Wadiura, Dimitri Benner, Arthur Hosmann, Shawn Hervey-Jumper, Engelbert Knosp, Karl Roessler, Mitchel S Berger and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Lasers in surgery and medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Mario MischkulnigDepartment of Neurosurgery, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.ORCID 0000-0001-5478-0792
Barbara KieselDepartment of Neurosurgery, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Martin BorkovecDepartment of Neurosurgery, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Lisa I WadiuraDepartment of Neurosurgery, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Dimitri BennerDepartment of Neurosurgery, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Arthur HosmannDepartment of Neurosurgery, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Shawn Hervey-JumperDepartment of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, California, 94143.
Engelbert KnospDepartment of Neurosurgery, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Karl RoesslerDepartment of Neurosurgery, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Mitchel S BergerDepartment of Neurological Surgery, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, California, 94143.
Georg WidhalmDepartment of Neurosurgery, Medical University Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Comprehensive Cancer Center Vienna · ATMedical University of Vienna · ATUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesFluorescence-guided resection of glioblastomas (GBM) using 5-aminolevulinic acid (5-ALA) improves intraoperative tumor visualization and is thus widely used nowadays. During resection, different fluorescence levels can usually be distinguished within the same tumor. Recently, we demonstrated that strong, vague, and no fluorescence correspond to distinct histopathological characteristics in newly diagnosed GBM. However, the qualitative fluorescence classification by the neurosurgeon is subjective and currently no comprehensive data on interobserver variability is available. The aim of this study was thus to investigate the interobserver variability in the classification of 5-ALA fluorescence levels in newly diagnosed GBM. STUDY DESIGN/MATERIALS AND

methodsA questionnaire investigating the interobserver variability in 5-ALA fluorescence quantification was performed at a nation-wide neurosurgical oncology meeting. The participants involved in the neurosurgical/neurooncological field were asked to categorize 30 cases of 5-ALA fluorescence images derived from GBM resection on a lecture hall screen according to the widely used three-tier fluorescence classification scheme (negative, vague, or strong fluorescence). Additionally, participants were asked for information on their medical background such as specialty, level of training, and experience with 5-ALA fluorescence-guided procedures. Interobserver agreement was defined as the calculated mean κ values for each observer.

resultsA total of 36 questionnaires were included in the final analysis. The mean average κ value in fluorescence classification within the entire cohort was 0.71 ± 0.12 and 29 (81%) participants had a substantial or almost perfect interobserver agreement (κ values 0.6-1.0). Interobserver agreement was significantly higher in neurosurgeons (mean κ: 0.83) as compared with non-neurosurgeons involved in the neurooncological field (mean κ: 0.52; P < 0.001). Furthermore, interobserver agreement was significantly higher in participants who had experience with at least 25 5-ALA fluorescence-guided surgeries (mean κ: 0.87) compared with less experienced colleagues (mean κ: 0.82; P = 0.039).

conclusionOur study found a high interobserver agreement in the qualitative classification of different 5-ALA fluorescence levels in newly diagnosed GBM. Interobserver agreement increases significantly in more experienced participants and therefore a high level of experience is crucial for reliable intraoperative fluorescence classification. Lasers Surg. Med. © 2020 The Authors. Lasers in Surgery and Medicine published by Wiley Periodicals, Inc.

Indexed as

Aminolevulinic AcidGlioblastomaCohort StudiesHumansObserver VariationAminolevulinic Acid5-ALAfluorescence levelshigh interobserver agreementinterobserver variabilitynewly diagnosed glioblastoma

Identifiers

PMID32147864
PMCPMC7586784
OpenAlexW3012195891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.